BRCA1 and cancer: To inform clinical management strategies and optimize guidelines for cancer risk management in female and male BRCA1/2 carriers, we comprehensively assess the associations of BRCA1/2 PVs with risks of 22 cancers, other than female breast and ovarian cancers.